/Revvity%20Inc_%20logo%20on%20phone%20and%20site%20by-%20T_Schneier%20via%20Shutterstock.jpg)
Waltham, Massachusetts-based Revvity, Inc. (RVTY) is a global provider of health sciences technologies and services. With a market cap of $15.4 billion, the company offers instruments, reagents, software, and solutions for genetic testing, disease detection, and drug discovery, serving pharmaceutical, biotech, and healthcare organizations.
Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Revvity fits this criterion perfectly, exceeding the mark. Revvity stands out in the market for its comprehensive integration of advanced informatics and detection technologies that streamline genomic workflows and enhance the early detection of genetic disorders.